@0zkphilip@AlgodTrading You do realize supply is relative right and what matters is the % that is circulating.
2 bil circulating of 4 bil total is better than 100 mil circulating of 500 mil total...
The total amount of tokens is irrelevant.
My $NOCK thesis:
If AI cryptos like $TAO pump then NOCK pumps.
If they dont - then NOCK still pumps. Why? Because it is a low enough market cap where even someone who doesnt think the market is bullish would still buy and hold due to its
Potential ROI.
You cant lose.
$TAO holders. This one is personal.
I live with an autoimmune disease. I know what the standard of care looks like. I know what corticosteroids do to your body when you have to rely on them for years.
So when @metanova_labs, SN68, announced its new IL-6 target, I paid attention and locked in to what they are doing.
Autoimmune disease affects roughly 50 million Americans and around 8% of the global population.
Lupus. Rheumatoid arthritis. Crohn’s. MS. Psoriasis. Hashimoto’s.
For many patients, long-term steroid use is still the fallback. The side effects are so brutal.
Osteoporosis. Cataracts. Glaucoma. Metabolic damage. Adrenal suppression. Weight gain. Mood instability.
IL-6 is one of the major inflammatory signals in the body. If you can target it cleanly, you can potentially treat inflammation without destroying everything else around it.
That is why IL-6 inhibitors are already a multi-billion dollar market.
Actemra. Kevzara. Treatments that can run tens of thousands per patient per year.
Now, NOVA is bringing that into Bittensor.
Their last nanobody target was PD-L1 for cancer immunotherapy. They received 8,446 unique nanobody submissions from an open decentralized competition.
Now, they are moving to IL-6 in partnership with Yalotein, with top submissions eligible for wet lab validation.
That is the important part.
This is not just AI generating molecules for a dashboard.
This is a decentralized virtual screening flowing toward real biologics development.
And if it wasn't for biologics, my quality of life would be so different now!
NOVA is also making the chemical search competition more exploration focused. Molecules that are too chemically similar will be rejected.
That matters because in drug discovery, making 1,000 versions of the same idea is easy.
Finding genuinely different scaffolds that actually work is the hard part.
That is where real breakthroughs come from.
This is why NOVA is different from most AI drug discovery.
NOVA is hundreds of miners competing in parallel, paid in $TAO, ranked by results, and pushing the best candidates toward wet lab testing.
Cancer, on the one hand.
Inflammation on the next.
What I am watching now:
How many IL-6 submissions come in compared to the 8,446 from PD-L1.
Whether the new exploration rules increase true chemical diversity.
Most importantly, what happens in wet lab validation with Yalotein.
Because that is where decentralized AI either proves itself in physical reality or it does not.
The people who need better autoimmune treatments are not thinking about crypto.
They are in waiting rooms or emergency rooms.
They are trying to work through pain.
They are choosing between rent and the medication.
They are hoping for something better, period.
If decentralized incentive driven discovery can shave years off the timeline or help lower the cost of better therapies, the impact is not just measured in token price.
It is measured in lives and quality of life itself.
That is why I care about this network.
It's not just a chart.
The work.
NOVA is one subnet. There are many more. Each one is writing its own version of this incredible mission while the market argues about everything else.
I will be watching IL-6 closely.
Personally and otherwise.
$TAO
Price for $KTA at 13 cents now be patient. 10 cents is coming then you buy and flip it for a quick 50% profits or maybe even 2x if the team has any decent news.
Dont trust anything regarding $KTA - remmeber they said they had 6 to 7 household name partners and still haven't revealed even 1.
Sub 10 cents incoming
The next catalyst for $KTA is Keeta Personal.
You can read what Gabe wrote - he’s the head of communications at Keeta.
Yeah, during this recent BTC pump Keeta didn’t perform because the market focus is on AI projects right now. But Keeta keeps building. Keeta is alive and evolving. It’s too early to bury this project.
Position accordingly.
@signalthevoid Bought keeta first week sold after a 100x during its hype cycle which is done now. All you people who came late and think you are early are delusional.
Dont trust anything regarding $KTA - remmeber they said they had 6 to 7 household name partners and still haven't revealed even 1.
Sub 10 cents incoming
Ty just dropped on Orbit VC with me and @Tubbs_the_Mayor . Here is the alpha:
🔒 Contracts signed. Joint venture partnership finalised. "The Big Guy"
🏗️ Fundamental network changes being built for this partner
6️⃣ 6 partner requests in 30 days from one anchor announcement 🏦 One partner sits under 70 fintechs. Onboard one. Get all 70.
🤫 A competitor L1 quietly approached Keeta asking for help
🏛️ Bank acquisition past due diligence. Change of control paperwork now being compiled.
📅 Q2 will start to show the community whats been happening behind the scene. Building blocks start interacting visibly now.
👤 Username anchor done.
🤖 AI agents built into Keeta since 2022
💬 "The gap between public perception and actual progress is widening daily." @schenkty@KeetaNetwork
keeta:native 🔥
It already did a 100x in 2025 dont be fooled by the "next SOL" narrative the hype cycle is done. The build up to test net/main net and reveal of household name partners carried it but now they haven't delivered any legit partners and have a weak community
$KTA